Catalyst Wire Dossier Catalyst Wire Dossier

propranolol 0.2% eye drops

propranolol
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for propranolol 0.2% eye drops, covering 2018-08-31 to 2018-08-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%) [Phase 2]

See pricing